Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
39,090,647
-
Share change
-
-1,670,997
-
Total reported value
-
$7,324,600,980
-
Put/Call ratio
-
133%
-
Price per share
-
$187.41
-
Number of holders
-
354
-
Value change
-
-$291,121,423
-
Number of buys
-
168
-
Number of sells
-
149
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q4 2017
As of 31 Dec 2017,
ABIOMED INC - COMMON STOCK (ABMD) was held by
354 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,090,647 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., Vanguard Group Inc, BAILLIE GIFFORD & CO, Palo Alto Investors, LLC, BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, AMERICAN CENTURY COMPANIES INC, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This page lists
354
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.